CBPO

China Biologic Products Holdings, Inc.
CBPO

Overview Fund Activity
Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

87 hedge funds and large institutions have $1.53B invested in China Biologic Products Holdings, Inc. in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-4
Holders Change %
-4.4%
% of All Funds
1.76%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
14
Increased
33
Reduced
31
Closed
17
Calls
$20.9M
Puts
$4.6M
Net Calls
+$16.3M
Net Calls Change
-$2.42M

Top Buyers

1
Capstone Investment Advisors
Capstone Investment Advisors
New York
$55.6M
2
Renaissance Technologies
Renaissance Technologies
New York
$93.7M
3
Deutsche Bank
Deutsche Bank
Germany
$19.8M
4
YCMGA
York Capital Management Global Advisors
New York
$161M
5
PCM
Pentwater Capital Management
Florida
$51.6M

Top Sellers

1
SGCM
Sand Grove Capital Management
United Kingdom
$0
2
Vanguard Group
Vanguard Group
Pennsylvania
$93.5M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$12M
4
MCP
Maso Capital Partners
Hong Kong
$98.1M
5
Marshall Wace
Marshall Wace
United Kingdom
$12M
Name Holding Trade Value Shares
Change 		Shares
Change %
QT
101
Quantbot Technologies
New York
– -$72K -709 Closed
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
– -$20K -200 Closed
PAM
103
Panagora Asset Management
Massachusetts
– -$9K -91 Closed
Macquarie Group
104
Macquarie Group
Australia
– -$6K -63 Closed
1 2 3 4
5